[Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children]. / Rekomendacje stosowania granulocytarnych i granulocytarno-makrofagowych czynników wzrostu w przebiegu leczenia przeciwnowotworowego u dzieci.
Przegl Lek
; 63(1): 1-6, 2006.
Article
em Pl
| MEDLINE
| ID: mdl-16892890
ABSTRACT
Neutropenia is the most often side effect during antineoplastic treatment. In this article current recommendations for clinical applications of granulocyte and granulocyto-macrophage hematopoietic factors and possibility of protection of neutropenia, and its serious complications in pediatric oncology are presented.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Fator Estimulador de Colônias de Granulócitos
/
Fator Estimulador de Colônias de Granulócitos e Macrófagos
/
Neoplasias
/
Neutropenia
/
Antineoplásicos
Tipo de estudo:
Guideline
Limite:
Child
/
Humans
Idioma:
Pl
Ano de publicação:
2006
Tipo de documento:
Article